维普期刊资源整合服务平台（V6.5）

178篇 您的检索式：作者名="PARISSIS JT"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	Depression in coronary artery disease: Novel pathophysiologicmechanisms and therapeutic implications显示文摘	Parissis JT Fountoulaki K Filippatos G	2007	Int J Cardiol2007，116，2：	1
2	Effects of darbepoetin - alpha on plasma pro - inflammatory cytokines, anti - inflammatory cytokine interleukin- 10 and soluble Fas/Fas ligand system in anemic patients with chronic heart failure 显示文摘	Kourea K Parissis JT Farmakis D	2008	Atherosclerosis2008，199，1：	1
3	Plasma profiles of peripheral monoeyte-related inflammatory markers in patients with arterial hypertension显示文摘	Parissis JT Korovesis S Giazitzoglou E	2002	Int J Cardiol2002，83，1：	1
4	Rationale and design of the multicenter randomized trial investigating the efficacy and safety of pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep study)显示文摘	Altenberger J Parissis JT Ulmer H	2010	Eur J Heart Fail2010，12，2：	1
5	Anti-infammatory and anti-apoptotic effects of levosimendan in decomensated heart failure:a novel mechnism of drug-induced improvement in contractile performance of the failing heart显示文摘	Paraskevaidis IA Parissis JT Kremastions D	2005	Curr Med Chem Cardiovasc Hematol Agent2005，3，3：	1
6	Etfects of darbepoetin o on right and left ventricular systolic and diastolic function in anemic patienLs withchronic heart failure secondary to ischemie or idiopathic dilated cardiomy- opathy 显示文摘	Parissis JT Kourea K Panou F	2008	Am Heart J2008，155，4：	1
7	Plasma B-typenat- riuretic peptide reduction predicts long-term response to levosi- mendan therapy in acutely decompensated chronic heart failure 显示文摘	Farmakis D Parissis JT Bistola V eta1	2010	IntJ Cardiol2010，139，1：	1
8	Effects of levesimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure显示文摘	Adamopoulos S Antaniades C	2004	Am J Cardiol2004，93，：	1
9	Anti inflammatory and an- ti apottotic effcets of levosimendan in decompensated heart failure: a novel mechanism of drug-induced im- proved in contractile performance of the failing heart 显示文摘	Paraskevaids IA Parissis JT	2005	Curr Med chem Cardiovasc Hematol Agents2005，3，3：	1
10	Clinical char- acteristics and predictors of in-hospital mortality in acute heart fail- ure with preserved left ventricular ejection fraction显示文摘	Parissis JT Ikonomidis I Rafouli-Stergiou P	2011	Am J Cardi- ol2011，107，1：	1
11	Novel biologic mecha- nisms of levosimendan and its effect on the failing heart 显示文摘	Parissis JT Andreadou I Bistola V	2008	Expert Opin Investig Drugs2008，17，：	1
12	Anti-inflammatory and antiapop totic effects of levosimendan in decompensated heart failure :a novelmechanism of drug2induced improvement in contractile performance of the failing heart显示文摘	Paraskevaidis IA Parissis JT Th Kremastinos D	2005	Curr Med Chem Cardiovasc HematolAgents2005，3，3：	1
13	Levo-simendan reduces plasma B-type natriuretic peptide and in-terleukin 6,and improves central hemodynamics in severe heart failure patients显示文摘	Adamopoulos S Parissis JT	2005	Int J Cardiol2005，99，3：	1
14	Effects of levosimendan on coronary artery flow and cardiac performance in patients with advanced heart failure 显示文摘	Ikonomidis I Parissis JT Paraskevaidis I	2007	Eur J Heart Fail2007，9，12：	1
15	A glossary of circulating cytokines in chronic heart failure显示文摘	Adamopoulos S Parissis JT Kremastinos DT	2001	Eur J Heart Fail2001，3，：	1
16	Growth hormone-induced reduction of soluble apoptosis mediators is associated with reverse cardiac remodeling and improvement of exercise capacity in patients with idiopathic dilated cardiomyopathy显示文摘	Parissis JT Adamopoulos S Karatzas D	2005	Eur J Cardiovasc Prev Reha bil2005，12，2：	1
17	Effects of Darbepoetin Alfa on plasma mediators of oxidative and nitrosative stress in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy 显示文摘	Parissis JT Kourea K Andreadou I	2009	Am J Cardiol2009，103，8：	1
18	Effects of darbepoet in-alpha on plasma pro-inflammatory cytok in es, anti-inflammatory cy- tokine interleukin-10 and soluble Fas/Fas ligand system in anemic pa- tients with chronic heart failure 显示文摘	KOUREA K PARISSIS JT FARMAKIS D	2008	Atherosclerosis2008，199，1：	1
19	Novel biologic mechanisms of levosimendan and its effect on the failing heart 显示文摘	Parissis JT Andreadou I Bistola V	2008	Expert OpinInvestig Drugs2008，17，8：	1
20	Effects of levosimendan on circulating pro inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure 显示文摘	Parissis JT Adamopoulos S Antoniades C	2004	Am J Cardiol2004，93，10：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示